Decentralized Clinical Trials: Driving Economic Value In Clinical Development
Sponsored by:
ICON
The advantages of decentralized clinical trials (DCTs) are well recognized. COVID-19 showed that the DCT model was not only viable but practicable as a means of overcoming physical constraints on patient access to trial sites.
Keep up with the top pharma business news of the week. On the go.
Sponsored by:
ICON